| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.AJO.2014.10.035 |
| P698 | PubMed publication ID | 25447115 |
| P50 | author | Tae Gon Lee | Q86104938 |
| P2093 | author name string | Jae Hui Kim | |
| Chul Gu Kim | |||
| Jong Woo Kim | |||
| Seul Gi Yoo | |||
| Han Joo Cho | |||
| Hyoung Seok Kim | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | geographic atrophy | Q47200750 |
| P304 | page(s) | 285-92.e1 | |
| P577 | publication date | 2014-11-05 | |
| P1433 | published in | American Journal of Ophthalmology | Q4744258 |
| P1476 | title | Risk factors for geographic atrophy after intravitreal ranibizumab injections for retinal angiomatous proliferation | |
| P478 | volume | 159 |
| Q92456774 | A Review of Macular Atrophy of the Retinal Pigment Epithelium in Patients with Neovascular Age-Related Macular Degeneration: What is the Link? Part II |
| Q47779475 | An 8-year follow-up of anti-vascular endothelial growth factor treatment with a treat-and-extend modality for neovascular age-related macular degeneration |
| Q53818467 | Antiangiogenic activity of PLGA-Lupeol implants for potential intravitreal applications. |
| Q89617984 | Changes in the Ganglion Cell-inner Plexiform Layer after Consecutive Intravitreal Injections of Anti-vascular Endothelial Growth Factor in Age-related Macular Degeneration Patients |
| Q94686967 | Clinical outcomes of 1 + PRN and 3 + Q3M regimens of intravitreal conbercept injection for exudative age-related macular degeneration |
| Q89677865 | Different conbercept injection strategies for the treatment of exudative age-related macular degeneration: A retrospective cohort study |
| Q28074640 | Geographic Atrophy and Choroidal Neovascularization in the Same Eye: A Review |
| Q90455502 | Incidence and Progression of Nongeographic Atrophy in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Clinical Trial |
| Q47108998 | Macular Atrophy Development and Subretinal Drusenoid Deposits in Anti-Vascular Endothelial Growth Factor Treated Age-Related Macular Degeneration. |
| Q51248665 | Macular atrophy in patients with long-term anti-VEGF treatment for neovascular age-related macular degeneration. |
| Q35872677 | Outcomes in Eyes with Retinal Angiomatous Proliferation in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT). |
| Q26751293 | Regulation of signaling events involved in the pathophysiology of neovascular AMD |
| Q33846379 | Short-term efficacy of intravitreal Aflibercept injections for retinal angiomatous proliferation |
| Q42364456 | Spotlight on reticular pseudodrusen. |
| Q86551292 | Two-year results of combined intravitreal ranibizumab and photodynamic therapy for retinal angiomatous proliferation |
| Q53198723 | Type 1 neovascularization may confer resistance to geographic atrophy amongst eyes treated for neovascular age-related macular degeneration. |
| Q36911004 | VEGF-B inhibits hyperglycemia- and Macugen-induced retinal apoptosis |
| Q53018746 | [Atrophy of the macula in the context of its wet, age-related degeneration : An inescapable consequence of anti-VEGF therapy?] |
Search more.